Evidence map›Paper›PMID 8139540›Full record

ArticleMolecular and cellular biology1994

The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.

M Selvakumaran, H K Lin, R T Sjin, J C Reed, D A Liebermann, B Hoffman

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 185 citations in OpenAlex.

  1. Review
  2. Article
  3. Gadd45 Proteins in Immunity 2.0.Advances in experimental medicine and biology · 2022
    Article
  4. GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.Advances in experimental medicine and biology · 2022
    Article
  5. Gadd45 in Normal Hematopoiesis and Leukemia.Advances in experimental medicine and biology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. GADD45 proteins: central players in tumorigenesis.Current molecular medicine · 2012
    Review
  14. Review
  15. Article
  16. Article
  17. Gadd45 stress sensors in malignancy and leukemia.Critical reviews in oncogenesis · 2011
    Review
  18. MYBBP1A: a new Ipr1's binding protein in mice.Molecular biology reports · 2010
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M SelvakumaranDepartment of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia 19104-6059.
H K Lin
R T Sjin
J C Reed
D A Liebermann
B Hoffman
University of Pennsylvania · US

Funding

MYELOPOIESIS, LEUKEMIA &ITS SUPPRESSION: MOLECULAR GENER01CA043618 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LIEBERMANN, DAN A · 1990 to 2000
$270k
GENE DISSECTION OF MYELOID DIFFERENTIATION &LEUKEMIASR01CA051162 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HOFFMAN, BARBARA · 1992 to 1996
–
NCI NIH HHS 1RO1CA43618NCI NIH HHS 1RO1CA51162
6 · The paper itself

Abstract

Cell numbers are regulated by a balance among proliferation, growth arrest, and programmed cell death. A profound example of cell homeostasis, controlled throughout life, is the complex process of blood cell development, yet little is understood about the intracellular mechanisms that regulate blood cell growth arrest and programmed cell death. In this work, using transforming growth factor beta 1 (TGF beta 1)-treated M1 myeloid leukemia cells and genetically engineered M1 cell variants, the regulation of growth arrest and apoptosis was dissected. Blocking of early expression of MyD118, a novel differentiation primary response gene also shown to be a primary response gene induced by TGF beta 1, delayed TGF beta 1-induced apoptosis, demonstrating that MyD118 is a positive modulator of TGF beta 1-mediated cell death. Elevated expression of bcl-2 blocked the TGF beta 1-induced apoptotic pathway but not growth arrest induced by TGF beta 1. Deregulated expression of either c-myc or c-myb inhibited growth arrest and accelerated apoptosis, demonstrating for the first time that c-myb plays a role in regulating apoptosis. In all cases, the apoptotic response was correlated with the level of MyD118 expression. Taken together, these findings demonstrate that the primary response gene MyD118 and the c-myc, c-myb, and bcl-2 proto-oncogenes interact to modulate growth arrest and apoptosis of myeloid cells.

Indexed as

Antigens, DifferentiationGenes, mycProto-OncogenesAnimalsApoptosisCell DivisionCell LineClone CellsGADD45 ProteinsGene Expression Regulation, NeoplasticGenetic VariationKineticsLeukemia, ExperimentalLeukemia, MyeloidMicePolymerase Chain ReactionAntigens, DifferentiationGadd45b protein, mouseGADD45 ProteinsProteinsProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mybTransforming Growth Factor beta

Identifiers

PMID8139540
PMCPMC358602
OpenAlexW2093873750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.